Gentherm THRM
$28.13 −$2.06 (-6.82%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.13 0.00%
Open$29.61
Prev close$30.19
Day range$27.99 – $30.23
Volume1.15M
Market cap$1.48B
P/E (TTM)100.5
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$405.10M+4.7% YoY
Operating profit$19.20M-31.0% YoY
Net profit-$2.59M-117.3% YoY
Diluted EPS-$0.08-116.3% YoY
Free cash flow$25.51M-44.7% YoY
Operating cash flow$33.74M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin23.7%
Operating margin4.6%
Net margin0.6%
Return on equity1.3%
Return on assets0.6%
Return on invested capital1.6%
Current ratio2.05
Liabilities / assets53.8%
Cash & investments$252.10M
Total debt$362.91M
Net cash (debt)-$110.81M
Free cash flow / sales1.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $405.10M | $416.17M | $393.71M | $1.50B | $382.79M |
| Total Operating Revenue | $405.10M | $416.17M | $393.71M | $1.50B | $382.79M |
| Cost of Revenue | $310.80M | $319.74M | $296.48M | $1.14B | $291.99M |
| Gross Profit | $94.30M | $96.43M | $97.23M | $362.18M | $90.80M |
| Operating Expense | $75.10M | $79.77M | $79.25M | $264.80M | $71.16M |
| Selling and Admin Expenses | $51.64M | $55.71M | $55.31M | $170.05M | $47.61M |
| Research & Development | $23.47M | $24.07M | $23.95M | $94.76M | $23.56M |
| Operating Profit | $19.20M | $16.65M | $17.98M | $97.37M | $19.64M |
| Net Non-Operating Interest Income (Expense) | -$3.83M | -$3.29M | -$2.63M | -$13.81M | -$2.90M |
| Non-Operating Interest Expense | $3.83M | $3.29M | $2.63M | $13.81M | $2.90M |
| Other Income (Expense) | -$4.53M | -$6.04M | -$7.73M | -$47.73M | -$6.41M |
| Gain on Sale of Security | $193,000.00 | -$237,000.00 | -$1.06M | -$28.42M | -$1.02M |
| Special Income (Charges) | -$4.84M | -$5.96M | -$6.69M | -$14.67M | -$1.87M |
| -Less:Restructuring and Mergern & Acquisition | $4.84M | $5.96M | $6.69M | $12.48M | $1.87M |
| -Gain on Sale of Property/Plant/Equipment | $0.00 | $0.00 | $0.00 | -$2.20M | $0.00 |
| Other Non-Operating Income (Expenses) | $116,000.00 | $162,000.00 | $22,000.00 | -$4.64M | -$3.52M |
| Pretax Profit | $10.84M | $7.32M | $7.61M | $35.84M | $10.33M |
| Tax | $13.43M | $2.90M | $3.40M | $17.55M | $7.35M |
| Net Profit | -$2.59M | $4.42M | $4.22M | $18.29M | $2.99M |
| Profit from Continuing Operations | -$2.59M | $4.42M | $4.22M | $18.29M | $2.99M |
| Net Income to Parent Company | -$2.59M | $4.42M | $4.22M | $18.29M | $2.99M |
| Net Income to Common Stockholders | -$2.59M | $4.42M | $4.22M | $18.29M | $2.99M |
| Basic EPS | -$0.08 | $0.14 | $0.14 | $0.60 | $0.10 |
| Diluted EPS | -$0.08 | $0.14 | $0.14 | $0.59 | $0.10 |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.56B | $1.49B | $1.43B | $1.40B | $1.40B |
| Total Current Assets | $927.48M | $880.01M | $826.20M | $776.95M | $776.95M |
| Cash and Cash Equivalents & Short-Term Investments | $252.10M | $213.17M | $177.40M | $160.83M | $160.83M |
| -Cash and Cash Equivalents | $252.10M | $213.17M | $177.40M | $160.83M | $160.83M |
| Receivables | $357.94M | $370.55M | $346.67M | $318.40M | $318.40M |
| -Accounts Receivable | $326.22M | $338.85M | $307.07M | $281.08M | $281.08M |
| -Notes Receivable | $16.49M | $11.19M | $21.61M | $13.49M | $13.49M |
| -Taxes Receivable | $15.24M | $20.51M | $17.99M | $23.83M | $23.83M |
| Prepaid Assets | $12.25M | $12.92M | $10.47M | $9.21M | $9.21M |
| Inventory | $263.49M | $244.54M | $256.97M | $252.70M | $252.70M |
| Other Current Assets | $40.80M | $38.52M | $32.36M | $31.28M | $31.28M |
| Total Non-Current Assets | $634.82M | $613.19M | $604.09M | $619.48M | $619.48M |
| Net PPE | $312.24M | $319.57M | $313.69M | $327.14M | $327.14M |
| -Gross PPE | $312.24M | $319.57M | $313.69M | $648.70M | $648.70M |
| Goodwill and Other Intangible Assets | $186.12M | $156.81M | $159.06M | $161.71M | $161.71M |
| -Goodwill | $122.26M | $107.11M | $107.80M | $108.92M | $108.92M |
| -Other Intangible Assets | $63.86M | $49.70M | $51.25M | $52.80M | $52.80M |
| Non-Current Deferred Assets | $93.85M | $92.96M | $93.86M | $93.55M | $93.55M |
| Other Non-Current Assets | $42.62M | $43.85M | $37.48M | $37.08M | $37.08M |
| Total Liabilities | $840.98M | $770.09M | $713.82M | $676.11M | $676.11M |
| Total Current Liabilities | $451.94M | $426.28M | $418.43M | $404.31M | $404.31M |
| Payables | $319.34M | $293.47M | $307.13M | $291.66M | $291.66M |
| -Accounts Payable | $298.18M | $270.38M | $277.03M | $260.49M | $260.49M |
| -Total Tax Payable | $21.16M | $23.09M | $30.09M | $31.17M | $31.17M |
| Current Accrued Expenses | $15.94M | $13.65M | $9.06M | $7.81M | $7.81M |
| Short-Term Debt and Capital Lease Obligation | $8.76M | $9.07M | $9.14M | $9.72M | $9.72M |
| -Current Debt | $912,000.00 | $868,000.00 | $36,000.00 | $73,000.00 | $73,000.00 |
| -Current Capital Lease Obligation | $7.85M | $8.20M | $9.10M | $9.65M | $9.65M |
| Other Current Liabilities | $55.77M | $67.89M | $59.24M | $45.20M | $45.20M |
| Total Non-Current Liabilities | $389.04M | $343.81M | $295.40M | $271.80M | $271.80M |
| Long Term Debt and Capital Lease Obligation | $362.00M | $316.01M | $264.30M | $237.11M | $237.11M |
| -Long Term Debt | $319.53M | $272.39M | $219.00M | $189.00M | $189.00M |
| -Long Term Capital Lease Obligation | $42.47M | $43.62M | $45.30M | $48.11M | $48.11M |
| Employee Benefits | $3.28M | $3.31M | $3.35M | $3.75M | $3.75M |
| Other Non-Current Liabilities | $23.76M | $24.48M | $27.75M | $30.94M | $30.94M |
| Total Equity | $721.32M | $723.12M | $716.47M | $720.32M | $720.32M |
| Stockholders' Equity | $721.32M | $723.12M | $716.47M | $720.32M | $720.32M |
| Capital Stock | $13.44M | $10.71M | $6.46M | $5.61M | $5.61M |
| -Common Stock | $13.44M | $10.71M | $6.46M | $5.61M | $5.61M |
| Additional Paid-In Capital | $1.59M | $1.59M | $1.59M | $1.59M | $1.59M |
| Retained Earnings | $720.13M | $722.72M | $718.30M | $714.09M | $714.09M |
| Gains/Losses Not Affecting Retained Earnings | -$13.85M | -$11.91M | -$9.89M | -$964,000.00 | -$964,000.00 |
| -Accumulated Depreciation | – | – | – | -$321.56M | -$321.56M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $33.74M | $7.32M | -$5.04M | $116.79M | $28.97M |
| Net cash flow from continuing operations | $33.74M | $7.32M | -$5.04M | $116.79M | $28.97M |
| Net Income from Continuing Operations | -$2.59M | $4.42M | $4.22M | $18.29M | $2.99M |
| Gain/Loss from Continuing Operations | -$125,000.00 | $152,000.00 | $94,000.00 | $3.03M | $354,000.00 |
| Depreciation & Depletion & Amortization | $15.46M | $14.52M | $14.22M | $53.38M | $13.90M |
| Deferred Tax | -$872,000.00 | -$3.57M | -$5.11M | -$22.34M | -$9.50M |
| Other Non-Cash Items | -$2.47M | $807,000.00 | $649,000.00 | $34.73M | $3.77M |
| Change in Working Capital | $19.75M | -$14.94M | -$23.06M | $10.60M | $14.15M |
| -Change in Receivables | $14.65M | -$31.84M | -$26.28M | -$9.30M | $11.24M |
| -Change in Inventory | -$17.75M | $5.94M | -$10.32M | -$21.63M | -$1.49M |
| -Change in Payables and Accrued Expense | $27.08M | -$2.50M | $18.73M | $27.56M | -$5.95M |
| -Change in Other Current Assets | $2.41M | -$1.41M | -$2.41M | -$17.78M | $4.55M |
| -Change in Other Current Liabilities | -$6.63M | $14.86M | -$2.78M | $31.74M | $5.81M |
| Net cash flow from investing | -$42.37M | -$8.73M | -$5.65M | -$52.40M | -$22.62M |
| Net Cash Flow from Continuing Investing Activities | -$42.37M | -$8.73M | -$5.65M | -$52.40M | -$22.62M |
| Net PPE Purchase and Sale | -$8.34M | -$8.48M | -$5.65M | -$51.90M | -$22.30M |
| Net Intangibles Purchase and Sale | $129,000.00 | -$250,000.00 | $0.00 | -$1.24M | -$325,000.00 |
| Financing Cash Flow | $46.95M | $37.76M | $28.11M | -$42.48M | -$50,000.00 |
| Net Cash Flow from Continuing Financing Activities | $46.95M | $37.76M | $28.11M | -$42.48M | -$50,000.00 |
| Net Issuance Payments Of Debt | $47.19M | $40.96M | $29.96M | -$31.15M | -$37,000.00 |
| Net Common Stock Issuance | $0.00 | – | – | -$10.02M | $0.00 |
| Net Other Financing Charges | -$238,000.00 | -$3.21M | -$1.86M | -$1.32M | -$13,000.00 |
| Ending Cash Balance | $252.10M | $213.17M | $177.40M | $160.83M | $160.83M |
| Net Change in Cash | $38.32M | $36.34M | $17.42M | $21.91M | $6.30M |
| Beginning Cash Balance | $213.17M | $177.40M | $160.83M | $134.13M | $154.25M |
| Effect of Exchange Rate Changes | $608,000.00 | -$566,000.00 | -$848,000.00 | $4.79M | $281,000.00 |
| Free Cash Flow | $25.51M | -$1.49M | -$10.69M | $59.88M | $6.35M |
| Net Other Investing Changes | – | – | – | $745,000.00 | $1,000.00 |
| Proceeds from Stock Option Exercised | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on THRM.
Sign in to join the discussion.